De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist

Summary: Lasso-grafting (LG) technology is a method for generating de novo biologics (neobiologics) by genetically implanting macrocyclic peptide pharmacophores, which are selected in vitro against a protein of interest, into loops of arbitrary protein scaffolds. In this study, we have generated a n...

Full description

Bibliographic Details
Main Authors: Yamato Komatsu, Naohiro Terasaka, Katsuya Sakai, Emiko Mihara, Risa Wakabayashi, Kunio Matsumoto, Donald Hilvert, Junichi Takagi, Hiroaki Suga
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004221012712
_version_ 1818927843640344576
author Yamato Komatsu
Naohiro Terasaka
Katsuya Sakai
Emiko Mihara
Risa Wakabayashi
Kunio Matsumoto
Donald Hilvert
Junichi Takagi
Hiroaki Suga
author_facet Yamato Komatsu
Naohiro Terasaka
Katsuya Sakai
Emiko Mihara
Risa Wakabayashi
Kunio Matsumoto
Donald Hilvert
Junichi Takagi
Hiroaki Suga
author_sort Yamato Komatsu
collection DOAJ
description Summary: Lasso-grafting (LG) technology is a method for generating de novo biologics (neobiologics) by genetically implanting macrocyclic peptide pharmacophores, which are selected in vitro against a protein of interest, into loops of arbitrary protein scaffolds. In this study, we have generated a neo-capsid that potently binds the hepatocyte growth factor receptor MET by LG of anti-MET peptide pharmacophores into a circularly permuted variant of Aquifex aeolicus lumazine synthase (AaLS), a self-assembling protein nanocapsule. By virtue of displaying multiple-pharmacophores on its surface, the neo-capsid can induce dimerization (or multimerization) of MET, resulting in phosphorylation and endosomal internalization of the MET-capsid complex. This work demonstrates the potential of the LG technology as a synthetic biology approach for generating capsid-based neobiologics capable of activating signaling receptors.
first_indexed 2024-12-20T03:19:27Z
format Article
id doaj.art-f66388c0f64b4cedba1f72a4ac812d78
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-12-20T03:19:27Z
publishDate 2021-11-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-f66388c0f64b4cedba1f72a4ac812d782022-12-21T19:55:15ZengElsevieriScience2589-00422021-11-012411103302De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonistYamato Komatsu0Naohiro Terasaka1Katsuya Sakai2Emiko Mihara3Risa Wakabayashi4Kunio Matsumoto5Donald Hilvert6Junichi Takagi7Hiroaki Suga8Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan; Corresponding authorDivision of Tumor Dynamics and Regulation, Cancer Research Institute, and WPI-Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma, Kanazawa-shi, Ishikawa 920-1192, JapanLaboratory of Protein Synthesis and Expression, Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita-shi, Osaka 565-0871, JapanDepartment of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDivision of Tumor Dynamics and Regulation, Cancer Research Institute, and WPI-Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma, Kanazawa-shi, Ishikawa 920-1192, JapanLaboratory of Organic Chemistry, ETH Zürich, 8093 Zürich, SwitzerlandLaboratory of Protein Synthesis and Expression, Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita-shi, Osaka 565-0871, JapanDepartment of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan; Corresponding authorSummary: Lasso-grafting (LG) technology is a method for generating de novo biologics (neobiologics) by genetically implanting macrocyclic peptide pharmacophores, which are selected in vitro against a protein of interest, into loops of arbitrary protein scaffolds. In this study, we have generated a neo-capsid that potently binds the hepatocyte growth factor receptor MET by LG of anti-MET peptide pharmacophores into a circularly permuted variant of Aquifex aeolicus lumazine synthase (AaLS), a self-assembling protein nanocapsule. By virtue of displaying multiple-pharmacophores on its surface, the neo-capsid can induce dimerization (or multimerization) of MET, resulting in phosphorylation and endosomal internalization of the MET-capsid complex. This work demonstrates the potential of the LG technology as a synthetic biology approach for generating capsid-based neobiologics capable of activating signaling receptors.http://www.sciencedirect.com/science/article/pii/S2589004221012712PeptidesBiotechnologySynthetic biology
spellingShingle Yamato Komatsu
Naohiro Terasaka
Katsuya Sakai
Emiko Mihara
Risa Wakabayashi
Kunio Matsumoto
Donald Hilvert
Junichi Takagi
Hiroaki Suga
De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist
iScience
Peptides
Biotechnology
Synthetic biology
title De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist
title_full De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist
title_fullStr De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist
title_full_unstemmed De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist
title_short De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist
title_sort de novo peptide grafting to a self assembling nanocapsule yields a hepatocyte growth factor receptor agonist
topic Peptides
Biotechnology
Synthetic biology
url http://www.sciencedirect.com/science/article/pii/S2589004221012712
work_keys_str_mv AT yamatokomatsu denovopeptidegraftingtoaselfassemblingnanocapsuleyieldsahepatocytegrowthfactorreceptoragonist
AT naohiroterasaka denovopeptidegraftingtoaselfassemblingnanocapsuleyieldsahepatocytegrowthfactorreceptoragonist
AT katsuyasakai denovopeptidegraftingtoaselfassemblingnanocapsuleyieldsahepatocytegrowthfactorreceptoragonist
AT emikomihara denovopeptidegraftingtoaselfassemblingnanocapsuleyieldsahepatocytegrowthfactorreceptoragonist
AT risawakabayashi denovopeptidegraftingtoaselfassemblingnanocapsuleyieldsahepatocytegrowthfactorreceptoragonist
AT kuniomatsumoto denovopeptidegraftingtoaselfassemblingnanocapsuleyieldsahepatocytegrowthfactorreceptoragonist
AT donaldhilvert denovopeptidegraftingtoaselfassemblingnanocapsuleyieldsahepatocytegrowthfactorreceptoragonist
AT junichitakagi denovopeptidegraftingtoaselfassemblingnanocapsuleyieldsahepatocytegrowthfactorreceptoragonist
AT hiroakisuga denovopeptidegraftingtoaselfassemblingnanocapsuleyieldsahepatocytegrowthfactorreceptoragonist